1. Home
  2. SRRK vs AIR Comparison

SRRK vs AIR Comparison

Compare SRRK & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$43.58

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo AAR Corp.

AIR

AAR Corp.

N/A

Current Price

$104.07

Market Cap

5.8B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SRRK
AIR
Founded
2012
1951
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.8B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
SRRK
AIR
Price
$43.58
$104.07
Analyst Decision
Strong Buy
Buy
Analyst Count
18
7
Target Price
$70.44
★ $154.50
AVG Volume (30 Days)
★ 2.2M
514.4K
Earning Date
11-13-2026
09-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1288.57
EPS
N/A
★ 1.00
Revenue
N/A
N/A
Revenue This Year
N/A
$11.56
Revenue Next Year
$1,978.85
$6.80
P/E Ratio
★ N/A
$102.70
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$76.10
52 Week High
$61.76
$154.00

Technical Indicators

Market Signals
Indicator
SRRK
AIR
Relative Strength Index (RSI) 30.08 33.24
Support Level $41.51 $101.48
Resistance Level $50.09 $121.24
Average True Range (ATR) 2.34 5.49
MACD -0.63 -1.02
Stochastic Oscillator 13.26 20.95

Price Performance

Historical Comparison
SRRK
AIR

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About AIR AAR Corp.

AAR Corp offers a broad line of products and services to commercial and government aerospace customers and operates internationally. It is a diversified provider of services and products to the commercial aviation and government and defense markets, serving aircraft fleet operators, original equipment manufacturers, independent service providers, and domestic and foreign military customers. It operates through the Parts Supply, Repair, Engineering and Software, Government Solutions, and Legacy Commercial Programs segments. The Parts Supply segment mainly consists of new parts distribution and sales of used serviceable material, including aircraft, engine, and airframe parts and components (USM), and generates the maximum revenue. It generates the maximum revenue from North America.

Share on Social Networks: